Our group and others have shown that Nrf2 expression, activity, and ARE-binding oscillate with diabetes progression resulting in lower levels of system xc- and GSH in diabetic animals [157,167,237,254]. This evidence concerns the gene NFE2L2 and diabetes mellitus.